Is it time to perform NGS testing for all brain tumors?

Cancer is a leading cause of death in the United States and throughout the world.

The U.S. Food and Drug Administration (FDA) has approved FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for intravenous use for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).

Pancreatic Cancer - Cholangiocarcinoma Clinical Trial

FDA Grants Fast Track Designation to Bemcentinib Combo in Advanced NSCLC

by Dr. C.H. Weaver 11/2021 It's “Movember” again - the annual event involving the growing of mustaches to raise awareness of men's health issues including prostate cancer, testicular cancer, and men's suicide is in full force. Cancer Connect salutes the Movember movement and has assembled the ...

Ask The Expert:Dr Aggarwal - University of Pennsylvania answered your questions about Lung Cancer

Dana-Farber Cancer Institute’s Dr. Jackman M. D. discusses the latest advances in the management of lung cancer

The National Consortium of Breast Centers (NCBC) on American Cancer Society’s Breast Cancer Screening Recommendations

Immunotherapy improves survival in cholangiocarcinoma and other biliary tract cancers.